Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 11.58
- Piotroski Score 3.00
- Grade Buy
- Symbol (ORIC)
- Company ORIC Pharmaceuticals, Inc.
- Price $9.59
- Changes Percentage (5.15%)
- Change $0.47
- Day Low $9.02
- Day High $9.72
- Year High $16.65
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/10/2025
- Fiscal Year End N/A
- Average Stock Price Target $20.00
- High Stock Price Target $21.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.80
- Trailing P/E Ratio -4.91
- Forward P/E Ratio -4.91
- P/E Growth -4.91
- Net Income $-100,697,000
Income Statement
Quarterly
Annual
Latest News of ORIC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
London's historic art scene is getting a tech upgrade
The UK's art scene is embracing technology like AI to stay competitive globally. London's art market holds 17% global share, with Frieze being a major hub. Phillips Auction, dating back to 1796, has a...
By CNBC | 21 hours ago -
Marysville's historic Bryant Field to be new home for pro baseball's High Wheelers
The High Wheelers, a baseball team that won the Pioneer League championship, will now play in Marysville at Bryant Field. They aim to enhance player development, community engagement, and fan experien...
By CBS News | 1 day ago -
Knicks' elite ball movement reaching historic levels
The Knicks, led by Jalen Brunson's playmaking, are excelling in sharing the ball with high assist numbers. Their improved offense and teamwork have elevated the team's performance, aiming to maintain ...
By New York Post | 1 day ago
